Pharmaceutical Industries
- Active Biotech - Lund, Sweden
- Bayer - Leverkusen, Germany
- Berlex - New Jersey, USA
- Biogen Idec - Cambridge, MA, USA
- BioPartners - Baar, Swiss
- Hoffmann La Roche - Basel, Switzerland
- Mucos - Geretsried, Germany
- Novartis - Basel, Switzerland
- Schering - Berlin, Germany
- Serono - Geneve, Switzerland
- TEVA - Petach Tiqva, Israel
- Wyeth Pharmaceuticals - Paris, France
Universities, Hospitals and Research Groups
- Roy Beck - Tampa, FL, USA
- Christian Confavreux - Lyon, France
- George Ebers - Oxford, UK
- Gilles Edan - Rennes, France
- Ludwig Kappos - Basel, Switzerland
- Allegheny General Hospital - Pittsburgh, USA
- Danish MS Group - Copenhagen, Denmark
- Ospedale San Raffaele - Milan, Italy
- Queens Square Hospital - London, UK
- London Clinical Trials Research Group - London, Ontario, Canada
- Marianne Strauss Clinic - Kempfenhausen, Germany
- Mayo Clinic - Rochester, MN, USA
- Sahlgrenska University Hospital - Gothenburg, Sweden
- St. Vincent's University Hospital - Dublin, Ireland
- University of British Columbia - Vancouver, Canada
- University of California - Los Angeles, CA, USA
- University of Cambridge - Cambridge, UK
- Vrije Universiteit - Amsterdam, Netherlands
- Georg-August-University - Goettingen, Germany
Randomized clinical trials datapackages
- Linomide Study - Active Biotech/Lund, Schweden
- Campath-1H - Addenbrookes Hospital/Cambridge, Great Britain
- ESIMS - Bayer/Leverkusen, Germany
- Antegren II - Biogen Elan/Cambridge, MA, USA
- CHAMPS - Biogen Idec/Cambridge, MA, USA
- Pivotal Avonex - Biogen Idec/Cambridge, MA, USA
- TNF alpha (Lenercept) - Hoffmann La Roche/Basel, Switzerland
- ONTT - Jaeb Center for Health Research/Tampa, FL, USA
- Canadian Cyclophosphmide PLEX - London Clinical Trials Research Group/London, Ontario, Kanada
- Sulfasalazine - Mayo Clinic/Rochester, MN, USA
- MS IVIG - Mayo Clinic/Rochester, MN, USA
- ON IVIG - Mayo Clinic/Rochester, MN, USA
- ESEMS - Mucos/Geretsried, Germany
- EU SPMS - Schering/Berlin, Germany
- Oral Interferone b - Schering/Berlin, Germany
- NA SPMS - Schering (Berlex)/Berlin, Germany
- Pivotal RRMS - Schering (Berlex)/Berlin, Germany
- ETOMS - Serono/Genf, Switzerland
- OWIMS - Serono/Genf, Switzerland
- PRISMS - Serono/Genf, Switzerland
- SPECTRIMS - Serono/Genf, Switzerland
- Copaxone - TEVA/Petach Tiqva, Israel
- AZAMS - University of California/Los Angeles, CA, USA
- Anti-CD4 - Vrije Universiteit/Amsterdam, Netherlands
- 3066A2-205 - Wyeth Pharmaceuticals/Paris, France
- FTY720 - Novartis/Basel, Switzerland
- ORIGIMS - BioPartners/Baar, Switzerland
- PRIVIG - Bayer Talecris/Leverkusen, Germany
- IVIG RRMS - Bayer/Leverkusen, Germany
Natural History, Registry, Observational datapackages
- Allegheny Database - Allegheny General Hospital/Pittsburgh, USA
- EDMUS Rennes - C.H.U. Pontchaillou/Rennes, Frankreich
- EDMUS Lyon - Hopital Neurologique/Lyon, Frankreich
- Kempfenhausen MS Cohort - Marianne Strauss Klinik/Kempfenhausen, Germany
- Olmsted county - Mayo Clinic/Rochester, MN, USA
- HSR misc - Ospedale San Raffaele/Mailand, Italien
- QS 14 years - Queens Square Hospital/London, Great Britain
- London Ontario - George Ebers/Oxford, Great Britain
- Gothenburg MS Incident Cohort Database - Sahlgrenska University Hospital/Goteborg, Sweden
- Costar - University of British Columbia/Vancouver, Canada
- Deoxyspergualin - University Hospital, Behring/Basel, Switzerland
- VU scale - Vrije Universiteit/Amsterdam, Netherlands
Special datasets
- MSK Mitox - Marianne Strauss Klinik/Kempfenhausen, Germany
- Pediatric MS Göttingen - Georg-August-Universität/Göttingen, Germany
- Pediatric MS Rotterdam - ERASMUS MC/Rotterdam, Netherlands
- Danish MS Register - Danish MS Group/Kopenhagen, Denmark
- RRMS IFN Response Database - St. Vincent's University Hospital/Dublin, Ireland
- Basel Microarray data - University Hospital/Basel, Switzerland
Further Cooperations
- A.R.T. tracking systems
Scientific cooperation
The Sylvia Lawry Centre remains interested in data from other MS studies and would like to include them at the disposal of the research institution.
Contact: Dr. Martin Daumer
| Donors |